Kristen Oelschlager's most recent trade in Castle Biosciences Inc was a trade of 48,367 Restricted Stock Units done . Disclosure was reported to the exchange on March 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2026 | 48,367 | 48,367 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 25,771 | 45,839 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 13,811 | 27,621 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2026 | 11,960 | 35,878 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.17 per share. | 03 Mar 2026 | 6,792 | 39,047 (0%) | 0% | 28.2 | 191,331 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.57 per share. | 03 Mar 2026 | 2,427 | 20,068 (0%) | 0% | 27.6 | 66,912 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 9,207 | 21,530 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 9,207 | 9,207 | - | - | Performance-Based Stock Unit | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 17 Dec 2025 | 14,888 | 12,323 (0%) | 0% | 39.3 | 585,292 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 15,961 | 15,961 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 15,961 | 28,284 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 6,170 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2025 | 6,170 | 29,763 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.25 per share. | 09 Dec 2025 | 4,691 | 23,593 (0%) | 0% | 38.3 | 179,431 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.02 per share. | 09 Dec 2025 | 2,552 | 27,211 (0%) | 0% | 38.0 | 97,027 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 35.10 per share. | 11 Nov 2025 | 18,932 | 12,323 (0%) | 0% | 35.1 | 664,513 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 25.04 per share. | 31 Oct 2025 | 12,678 | 27,569 (0%) | 0% | 25.0 | 317,457 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.69 per share. | 27 Aug 2025 | 18,007 | 153,793 (0%) | 0% | 21.7 | 390,572 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.69 per share. | 27 Aug 2025 | 18,007 | 100,937 (0%) | 0% | 21.7 | 390,572 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.02 per share. | 27 Aug 2025 | 12,677 | 141,116 (0%) | 0% | 22.0 | 279,135 | Common Stock |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2025 | 10,640 | 174,604 (1%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2025 | 10,640 | 0 | - | - | Performance-Based Stock Unit | |
| Castle Biosciences Inc | Kristen M. Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.36 per share. | 08 Aug 2025 | 2,804 | 171,800 (1%) | 0% | 19.4 | 54,285 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 47,838 | 47,838 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 13,811 | 41,432 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2025 | 13,811 | 167,604 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager M. | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.23 per share. | 04 Mar 2025 | 3,640 | 163,964 (0%) | 0% | 22.2 | 80,917 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 15,961 | 150,965 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 15,961 | 31,922 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 6,169 | 6,170 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 6,169 | 154,148 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.91 per share. | 09 Dec 2024 | 4,206 | 146,759 (0%) | 0% | 30.9 | 130,007 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,750 | 0 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2024 | 1,750 | 148,509 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.63 per share. | 09 Dec 2024 | 1,626 | 152,522 (0%) | 0% | 29.6 | 48,178 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.63 per share. | 09 Dec 2024 | 530 | 147,979 (0%) | 0% | 29.6 | 15,704 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 03 Sep 2024 | 4,582 | 136,091 (0%) | 0% | 29.0 | 132,869 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.97 per share. | 03 Sep 2024 | 1,250 | 134,841 (0%) | 0% | 30.0 | 37,461 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 10,641 | 143,477 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 10,640 | 10,640 | - | - | Performance-Based Stock Unit | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.83 per share. | 09 Aug 2024 | 2,804 | 140,673 (0%) | 0% | 26.8 | 75,231 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.71 per share. | 01 Aug 2024 | 8,764 | 137,061 (0%) | 0% | 22.7 | 199,074 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 23.77 per share. | 01 Aug 2024 | 4,225 | 132,836 (0%) | 0% | 23.8 | 100,428 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 22.06 per share. | 29 Jul 2024 | 2,793 | 145,825 (0%) | 0% | 22.1 | 61,622 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 21.22 per share. | 01 Jul 2024 | 2,793 | 148,618 (0%) | 0% | 21.2 | 59,279 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 55,243 | 55,243 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 8,000 | 16,610 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.38 per share. | 29 Dec 2023 | 8,000 | 150,302 (0%) | 0% | 3.4 | 27,040 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 3,418 | 0 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 29 Dec 2023 | 3,418 | 142,302 (0%) | 0% | 2.4 | 8,169 | Common Stock |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.36 per share. | 29 Dec 2023 | 1,197 | 138,884 (0%) | 0% | 2.4 | 2,825 | Common Stock |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 1,197 | 0 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 15,961 | 47,883 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 15,961 | 136,061 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 6,170 | 12,339 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 6,170 | 138,025 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.17 per share. | 09 Dec 2023 | 4,206 | 131,855 (0%) | 0% | 20.2 | 84,835 | Common Stock |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 1,750 | 1,750 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2023 | 1,750 | 138,149 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.17 per share. | 09 Dec 2023 | 1,626 | 136,399 (0%) | 0% | 20.2 | 32,796 | Common Stock |
| Castle Biosciences Inc | Oelschlager Kristen | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.17 per share. | 09 Dec 2023 | 462 | 137,687 (0%) | 0% | 20.2 | 9,319 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2022 | 7,178 | 0 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.39 per share. | 28 Dec 2022 | 7,178 | 118,914 (0%) | 0% | 2.4 | 17,155 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 63,844 | 63,844 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 6,170 | 18,509 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 6,170 | 113,554 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. | 09 Dec 2022 | 1,818 | 111,736 (0%) | 0% | 22.3 | 40,578 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 1,750 | 107,900 (0%) | 0% | 0 | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2022 | 1,750 | 3,500 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.32 per share. | 09 Dec 2022 | 516 | 107,384 (0%) | 0% | 22.3 | 11,517 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2022 | 6,692 | 105,873 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 42,550 | 42,550 | - | - | Stock option (right to buy) | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 24,679 | 24,679 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 1,750 | 5,250 | - | - | Restricted Stock Units | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Dec 2021 | 1,750 | 99,290 (0%) | 0% | - | Common Stock | |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.52 per share. | 10 Dec 2021 | 516 | 98,774 (0%) | 0% | 40.5 | 20,908 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.94 per share. | 27 Sep 2021 | 8,574 | 98,966 (0%) | 0% | 70.9 | 608,240 | Common Stock |
| Castle Biosciences Inc | Kristen Oelschlager | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 71.52 per share. | 27 Sep 2021 | 1,426 | 97,540 (0%) | 0% | 71.5 | 101,988 | Common Stock |